A fluo-marker to trace and a K vitamin to unveil: to better follow metabolism in multiple sclerosis
Medicomunicare Magazine | Health and Medical News
Secondary progressive multiple sclerosis (MS) is a relentless disease. Over time, patients experience worsening of physical, mental, and mood-related symptoms. There are currently several disease-modifying drugs on the market to help relapsing and remitting MS patients with minor and less severe relapses, but few drugs exist for patients with secondary progressive MS. Yet even as